Boehringer Ingelheim Rcv GmbH & Co KG

Boehringer Ingelheim Rcv GmbH & Co KG is a company in Wien, Austria that has taken part in 8 EU-funded projects since 2017, receiving €1.1M in EU funding.

EU funding received€1.1M
EU projects8
As coordinator0
Running now4
First EU project2017
Latest project2027
CountryAustria
EU registration (PIC)967904413
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Boehringer Ingelheim Rcv GmbH & Co KG's own share of each project, not the project's full budget.

  • Horizon Europe€541k · 4 projects
  • Horizon 2020€528k · 3 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • FlexCATAssociated partner

    Training program to engage flexible and disordered protein targets for therapeutic development: The oncogene β-catenin as showcase.

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

  • IDOH NextAssociated partner

    Master in Infectious Diseases and One Health-IDOHNext

    Erasmus+ (ERASMUS+) · 2026–2033 · Project on the EU portal ↗

  • ORFeusAssociated partner

    Decoding the dark proteome through interdisciplinary training and research

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • AdaptmetPartner

    Deconstructing adaptive evolution of metastasis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €270ktheir share
  • greenerRPPPartner

    Greener, more sustainable platforms for high-value recombinant protein production

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €270ktheir share
  • EvometPartner

    Deconstructing the evolution of metastasis

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €264ktheir share
  • SecretersPartner

    A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €264ktheir share
  • META-CANPartner

    Targeting the metabolism-immune system connections in Cancer

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • bioeconomy
  • cell metabolism
  • cell signaling
  • drug discovery
  • entrepreneurship
  • enzymes
  • genomes
  • immunology
  • immunotherapy
  • oncology
  • personalized medicine
  • proteomics
  • synthetic biology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime